Neuroinvasion of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2): future risk of epilepsy

References

• Beghi E, Giussani G, Nichols E, et al. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(4):357–375.
   PubMed Web of Science ®Google Scholar
• Allers K, Essue BM, Hackett ML, et al. The economic impact of epilepsy: a systematic review. BMC Neurol. 2015;15(1):245.
   PubMedGoogle Scholar
• Groff A, Kavanaugh M, Ramgobin D, et al. Gastrointestinal manifestations of COVID-19: a review of what We know. Ochsner J. 2021;21(2):177–180.
   PubMed Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098.
   PubMed Web of Science ®Google Scholar
• Reinhold A, Tzankov A, Matter MS, et al. Ocular pathology and occasionally detectable intraocular severe acute respiratory syndrome coronavirus-2 RNA in five fatal coronavirus disease-19 cases. Ophthalmic Res. 2021;64(5):785–792.
   PubMed Web of Science ®Google Scholar
• Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 post-mortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219–227.
   PubMed Web of Science ®Google Scholar
• Holtkamp M. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76(4):534–539.
   PubMed Web of Science ®Google Scholar
• Al Saiegh Fadi R, Ghosh A, Leibold MB, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020;91(8):846–848.
   PubMed Web of Science ®Google Scholar
• Baig AM. Deleterious outcomes in Long-Hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci. 2020;11(24):4017–4020.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Basu S, Majumdar K. Seizure after recovery from covid-19. J Family Med Prim Care. 2021;10(7):2713–2715.
   PubMedGoogle Scholar
• Hwang ST, Ahmad A, Ballout Usman Mirza Anup N, et al. Acute seizures occurring in association with SARS-CoV-2. Front Neurol. 2020;11:576329. November 5
   PubMed Web of Science ®Google Scholar
• Al-Dalahmah O, Thakur KT, Nordvig AS, et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun. 2020;8(1):147.
   PubMed Web of Science ®Google Scholar
• Fabbri VP, Foschini MP, Lazzarotto T, et al. Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases. Brain Pathol. 2021;31(1):205–210. https://doi.org/10.1111/bpa.12901
   PubMed Web of Science ®Google Scholar
• Matschke J, Lütgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a Post-Mortem case series. Lancet Neurol. 2020;19(11):919–29.
   PubMed Web of Science ®Google Scholar
• Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of Central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168–175.
   PubMed Web of Science ®Google Scholar
• Welcome MO, Mastorakis NE. Neuropathophysiology of coronavirus disease 2019: Neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology. 2021;29(4):939–963.
   PubMed Web of Science ®Google Scholar
• Fisicaro F, Di Napoli M, Liberto A, et al. Neurological sequelae in patients with COVID-19: a histopathological perspective. IJERPH. 2021;18(4):1415.
   Web of Science ®Google Scholar
• Reddy S, Younus I, Sridhar V, et al. Neuroimaging biomarkers of experimental epileptogenesis and refractory epilepsy. IJMS. 2019;20(1):220. January 8
   Google Scholar
• Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, et al. Miller fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601–5.
   PubMed Web of Science ®Google Scholar
• Steardo L, Steardo L, Zorec R, et al. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol. 2020;229(3):e13473.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Kang H, Li S, et al. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179–2184.
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis MLC, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637.
   PubMed Web of Science ®Google Scholar
• Salamanna F, Maglio M, Landini MP, et al. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne). 2020;7:594495.
   PubMed Web of Science ®Google Scholar
• Bösmüller H, Matter M, Fend F, et al. The pulmonary pathology of COVID-19. Virchows Arch. 2021;478(1):137–150.
   PubMed Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020;26:m1091.
   Google Scholar
• Legrand M, Bell S, Forni L, et al. Pathophysiology of COVID-19-Associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751–764.
   PubMed Web of Science ®Google Scholar
• Nasiri N, Sharifi H, Bazrafshan A, et al. Ocular manifestations of COVID-19: a systematic review and Meta-Analysis. JOVR. 2021;16(1):103–112.
   Google Scholar
• Barrantes FJ. Central nervous system targets and routes for SARS-CoV-2: Current views and new hypotheses. ACS Chem Neurosci. 2020;11(18):2793–2803.
   PubMed Web of Science ®Google Scholar
• Zubair AS, Lindsay S, McAlpine T, et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018–1027. August 1.
   PubMed Web of Science ®Google Scholar
• Lentsch Alex B, Ward PA. Regulation of inflammatory vascular damage. J Pathol. 2000;190(3):343–348.
   PubMed Web of Science ®Google Scholar
• Pan W, Stone KP, Hsuchou H, et al. Cytokine signaling modulates blood-brain barrier function. Curr Pharm Des. 2011;17(33):3729–3740.
   PubMed Web of Science ®Google Scholar
• Verhoog Quirijn P, Holtman L, Aronica E, et al. Astrocytes as guardians of neuronal excitability: Mechanisms underlying epileptogenesis. Front Neurol. 2020;11:591690. November 26.
   PubMed Web of Science ®Google Scholar
• Hojyo S, Uchida M, Tanaka K, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen. 2020;40(1):37.
   PubMed Web of Science ®Google Scholar
• Olbei M, Hautefort I, Modos D, et al. SARS-CoV-2 causes a different cytokine response compared to other cytokine Storm-Causing respiratory viruses in severely ill patients. Front Immunol. 2021;12:629193. (March 12021).
   PubMed Web of Science ®Google Scholar
• Park MD. Macrophages: a trojan horse in COVID-19? Nat Rev Immunol. 2020;20(6):351–351.
   PubMedGoogle Scholar
• Yapici-Eser H, Koroglu YE, Oztop-Cakmak O, et al. Neuropsychiatric symptoms of COVID-19 explained by SARS-CoV-2 proteins’ mimicry of human protein interactions. Front Hum Neurosci. 2021;15:656313. March 23.
   PubMed Web of Science ®Google Scholar
• Huth SF, Sung-Min C, Chiara R, et al. Neurological manifestations of coronavirus disease 2019: a comprehensive review and Meta-Analysis of the first 6 months of pandemic reporting. Front Neurol. 2021;12:664599. August 12.
   PubMed Web of Science ®Google Scholar
• Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;5(3):279–284.
   PubMedGoogle Scholar
• Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690.
   PubMed Web of Science ®Google Scholar
• Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060–70–e1070. August 25.
   Web of Science ®Google Scholar
• Scullen T, Keen J, Mathkour M, et al. Coronavirus 2019 (COVID-19)–associated encephalopathies and cerebrovascular disease: the New Orleans experience. World Neurosurg. 2020;141:e437–46.
   PubMed Web of Science ®Google Scholar
• Kremer S, Lersy F, de Sèze J, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297(2):E242–51.
   PubMed Web of Science ®Google Scholar
• Alyu F, Dikmen M. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr. 2017;29(1):1–16.
   PubMed Web of Science ®Google Scholar
• Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol. 2012;33(1):116–125.
   PubMed Web of Science ®Google Scholar
• Nikbakht F, Mohammadkhanizadeh A, Mohammadi E. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms. Mult Scler Relat Disord. 2020;46:102535.
   PubMed Web of Science ®Google Scholar
• Postnikova TY, Zubareva OE, Kovalenko AA, et al. Status epilepticus impairs synaptic plasticity in rat hippocampus and is followed by changes in expression of NMDA receptors. Biochemistry. 2017;82(3):282–290.
   PubMed Web of Science ®Google Scholar
• Rana A, Musto AE. The role of inflammation in the development of epilepsy. J Neuroinflammation. 2018;15(1):144.
   PubMedGoogle Scholar
• Roseti C, van Vliet EA, Pierangelo C, et al. GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: Implications for ictogenesis. Neurobiol Dis. 2015;82:311–320.
   PubMed Web of Science ®Google Scholar
• Samuelsson A-M, Jennische E, Hansson H-A, et al. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA a dysregulation and impaired spatial learning. Am J Physiol Regul Integr Comp Physiol. 2006;290(5):R1345–56.
   PubMed Web of Science ®Google Scholar
• Stellwagen D, Beattie EC, Seo JY, et al. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor. J Neurosci. 2005;25(12):3219–3228.
   PubMed Web of Science ®Google Scholar
• Viviani B, Bartesaghi S, Gardoni F, et al. Interleukin-1β enhances NMDA Receptor-Mediated intracellular calcium increase through activation of the src family of kinases. J Neurosci. 2003;23(25):8692–8700. September 24.
   PubMed Web of Science ®Google Scholar
• Levin SG, Godukhin OV. Modulating effect of cytokines on mechanisms of synaptic plasticity in the brain. Biochemistry. 2017;82(3):264–274.
   PubMed Web of Science ®Google Scholar
• Kincaid KJ, Justin C, Kung Alexander J, et al. Post-COVID seizure: a new feature of ‘Long-COVID. ENeurologicalSci. 2021;23:100340.
   PubMedGoogle Scholar
• Duong L, Prissilla X, Antonio L. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in downtown Los Angeles, early April 2020. Brain Behav Immun. 2020;87:33.
   PubMed Web of Science ®Google Scholar
• Ebrahimpour S, Afshar ZM, Mohseni S, et al. Neurologic manifestations in patients with COVID-19: a case series. Caspian J Intern Med 2020;11:557–560.
   PubMedGoogle Scholar
• Karimi N, Sharifi Razavi A, Rouhani N. Frequent convulsive seizures in an adult patient with COVID-19: a case report. Iran Red Crescent Med J. 2020;22(3).
   Web of Science ®Google Scholar
• Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–58.
   PubMed Web of Science ®Google Scholar
• Sohal S, Mansur M. COVID-19 presenting with seizures. IDCases. 2020;20:e00782.
   PubMed Web of Science ®Google Scholar
• Gómez-Enjuto S, Hernando-Requejo V, Lapeña-Motilva J, et al. Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-CoV-2 infected patient. Seizure. 2020;80:157–158.
   PubMed Web of Science ®Google Scholar
• Vollono C, Rollo E, Romozzi M, et al. Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure. 2020;78:109–112.
   PubMed Web of Science ®Google Scholar
• Dono F, Carrarini C, Russo M, et al. New-Onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report. Neurol Sci. 2021;42(1):35–38.
   PubMed Web of Science ®Google Scholar
• Henry BM, Vikse J, Benoit S, et al. Hyperinflammation and derangement of Renin-Angiotensin-Aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020;507:167–173.
   PubMed Web of Science ®Google Scholar
• Bermúdez S, Forero PA, Salej V, et al. Simultaneous arterial and venous brain infarctions in a patient with COVID-19: Case report. SN Compr Clin Med. 2021;3(12):2622–2625.
   PubMedGoogle Scholar
• Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14.
   PubMed Web of Science ®Google Scholar
• Merkler AE, Parikh NS, Mir S, et al. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. 2020;77(11):1366.
   Web of Science ®Google Scholar
• Misra S, Kolappa K, Prasad M, et al. Frequency of neurologic manifestations in COVID-19: a systematic review and Meta-Analysis. Neurology. 2021;97(23):e2269–81–e2281. December 7.
   Web of Science ®Google Scholar
• Mondal S, Quintili AL, Karamchandani K, et al. Thromboembolic disease in COVID-19 patients: a brief narrative review. J Intensive Care. 2020;8(1):70.
   PubMed Web of Science ®Google Scholar
• Mungmunpuntipantip R, Wiwanitkit V. COVID-19, neurovascular thrombotic problem and short summary on blood coagulation disorder: a brief review. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):6.
   PubMedGoogle Scholar
• Klok FA, Kruip M, van der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–150.
   PubMed Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099.
   PubMed Web of Science ®Google Scholar
• Conrad J, Pawlowski M, Dogan M, et al. Seizures after cerebrovascular events: Risk factors and clinical features. Seizure. 2013;22(4):275–282.
   PubMed Web of Science ®Google Scholar
• Ferro JM, Correia M, Rosas MJ, et al. Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2003;15(1-2):78–83.
   PubMed Web of Science ®Google Scholar
• Goyal G, Singh R. Predictors of presenting seizures in acute cerebral vein and dural sinus thrombosis. J Epilepsy Res. 2020;10(2):74–78.
   PubMedGoogle Scholar
• Ferro JM, Canhão P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: Results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004;35(3):664–670.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Kwan P. Epilepsy in elderly people. BMJ. 2005;331(7528):1317–1322.
   PubMed Web of Science ®Google Scholar
• Yong SJ. Persistent brainstem dysfunction in Long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12(4):573–580.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan RK, Kandasamy M. SARS-CoV-2-Mediated neuropathogenesis, deterioration of hippocampal neurogenesis and dementia. Am J Alzheimers Dis Other Demen. 2022;37:15333175221078418.
   Web of Science ®Google Scholar
• Solomon IH, Normandin E, Bhattacharyya S, et al. Neuropathological features of covid-19. N Engl J Med. 2020;383(10):989–992.
   PubMed Web of Science ®Google Scholar
• Thakur KT, Miller EH, Glendinning MD, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York presbyterian hospital. Brain. 2021;144(9):2696–2708. October 22.
   PubMedGoogle Scholar
• Chiveri L, Verrengia E, Muscia F, et al. Limbic encephalitis in a COVID-19 patient? J Neurovirol. 2021;27(3):498–500.
   PubMed Web of Science ®Google Scholar
• Mărgăritescu O, Mogoantă L, Pirici I, et al. Histopathological changes in acute ischemic stroke. Roman J Morphol Embryol. 2009;50(3):327–339.
   PubMed Web of Science ®Google Scholar
• Sashindranath M, Nandurkar HH. Endothelial dysfunction in the brain: Setting the stage for stroke and other cerebrovascular complications of COVID-19. Stroke. 2021;52(5):1895–1904.
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417–1418.
   PubMed Web of Science ®Google Scholar
• Hernández-Fernández F, Sandoval Valencia H, Barbella-Aponte RA, et al. Cerebrovascular disease in patients with COVID-19: Neuroimaging, histological and clinical description. Brain. 2020;143(10):3089–3103. October 1.
   PubMedGoogle Scholar
• Dani M, Dirksen A, Taraborrelli P, et al. Autonomic ­dysfunction in ‘long COVID’: Rationale, physiology and management strategies. Clin Med. 2021;21(1):e63–67–e67.
   Web of Science ®Google Scholar
• Nath A. Long-Haul COVID. Neurology. 2020;95(13):559–560.
   PubMed Web of Science ®Google Scholar
• Yong SJ. Long-Haul COVID-19: Putative pathophysiology, risk factors, and treatments. Med Pharmacol. 2020;12(4):573–580.
   Google Scholar
• Ksenija B. [Prophylactic use of antiepileptic drugs for posttraumatic epilepsy]. Med Pregl. 2009;62(11-12)(12):501–503.
   PubMedGoogle Scholar
• Schierhout G, Roberts I. Prophylactic antiepileptic agents after head injury: a systematic review. J Neurol Neurosurg Psychiatry. 1998;64(1):108–112. January 1.
   PubMed Web of Science ®Google Scholar